HUTCHMED (China) Limited Sponsored ADR HCM

13.94 0.04 0.29% as of 25 Sep
Market cap
$2.4B
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
548.51 630.20 838.00 426.41 356.13 227.98 204.89 214.11 241.20 216.08
Revenue Growth
(12.96%) (24.80%) 96.52% 19.73% 56.21% 11.27% (4.31%) (11.23%) 11.63% 21.25%
Cost of Revenue
336.35 348.88 384.45 311.10 258.23 188.52 160.15 143.94 175.82 156.33
Gross Profit
212.16 281.32 453.55 115.31 97.89 39.46 44.74 70.17 65.38 59.75
R&D Expenses
148.30 212.11 302.00 386.89 299.09 174.78 138.19 114.16 75.52 66.87
SG&A Expenses
103.03 112.91 133.18 136.11 127.13 61.35 52.93 48.65 43.28 39.58
Operating Income
(39.16) (43.70) 18.38 (407.69) (328.32) (196.67) (146.39) (92.64) (53.42) (46.70)
Non-operating Income/Expense
537.85 42.60 39.93 (2.73) 112.58 6.93 5.28 5.99 (0.12) (0.66)
Non-operating Interest Expenses
2.87 2.87 0.76 0.65 0.59 0.79 1.03 1.01 1.46 1.63
EBT
498.69 (1.11) 58.31 (410.42) (215.74) (189.73) (141.10) (86.65) (53.54) (47.36)
Income Tax Provision
63.61 7.19 4.51 (0.28) 11.92 4.83 3.27 3.96 3.08 4.33
Income after Tax
435.08 (8.30) 53.80 (410.14) (227.66) (194.56) (144.38) (90.62) (56.62) (51.69)
Share of Subsidiary Earnings
22.65 46.47 47.30 49.75 60.62 79.05 40.70 19.33 33.65 66.24
Dividends (Preferred)
— 0.00 — — — 0.00 — 0.00 0.00 —
Non-Controlling Interest
0.82 0.44 0.31 0.45 27.61 10.21 2.35 3.52 3.77 2.86
Net Income Common
456.91 37.73 100.78 (360.83) (194.65) (125.73) (106.02) (74.80) (26.74) 11.70
EPS (Basic)
2.66 0.22 0.59 (2.13) (1.23) (0.90) (0.80) (0.57) (0.22) 0.10
EPS (Diluted)
2.62 0.22 0.58 (2.13) (1.23) (0.90) (0.80) (0.57) (0.22) 0.10
Shares (Basic, Weighted)
171.66 171.07 169.93 169.43 158.54 139.59 133.14 132.85 123.43 119.43
Shares (Diluted, Weighted)
174.58 174.57 173.84 169.43 158.54 139.59 133.14 132.85 123.43 119.43
Gross Margin
38.68% 44.64% 54.12% 27.04% 27.49% 17.31% 21.84% 32.77% 27.11% 27.65%
EBIT Margin
(7.14%) (6.94%) 2.19% (95.61%) (92.19%) (86.27%) (71.45%) (43.27%) (22.15%) (21.61%)
EBT margin
90.92% (0.18%) 6.96% (96.25%) (60.58%) (83.23%) (68.87%) (40.47%) (22.20%) (21.92%)
Net Profit Margin
83.30% 5.99% 12.03% (84.62%) (54.66%) (55.15%) (51.75%) (34.94%) (11.08%) 5.41%
Free Cash Flow Margin
(16.19%) (2.77%) 22.27% (71.59%) (62.05%) (35.81%) (43.67%) (18.31%) (5.79%) (6.43%)
EBITDA
(25.85) (31.36) 26.58 (399.03) (321.13) (190.61) (141.44) (89.05) (50.84) (44.36)
EBIT
(39.16) (43.70) 18.38 (407.69) (328.32) (196.67) (146.39) (92.64) (53.42) (46.70)
Income from Continuous Operations
457.73 38.17 101.09 (360.39) (167.04) (115.52) (103.68) (71.29) (22.96) 14.56
Consolidated Net Income/Loss
457.73 38.17 101.09 (360.39) (167.04) (115.52) (103.68) (71.29) (22.96) 14.56
EPS (Basic, from Continuous Ops)
2.67 0.22 0.59 (2.13) (1.05) (0.83) (0.78) (0.54) (0.19) 0.12
EPS (Basic, Consolidated)
2.67 0.22 0.59 (2.13) (1.05) (0.83) (0.78) (0.54) (0.19) 0.12
EPS (Diluted, from Cont. Ops)
2.62 0.22 0.58 (2.13) (1.05) (0.83) (0.78) (0.54) (0.19) 0.12
Shares (Diluted, Average)
174.58 174.57 173.84 169.43 158.54 139.59 133.14 132.85 123.43 119.94
EPS (Diluted, Consolidated)
2.62 0.22 0.58 (2.13) (1.05) (0.83) (0.78) (0.54) (0.19) 0.12
EBITDA Margin
(4.71%) (4.98%) 3.17% (93.58%) (90.17%) (83.61%) (69.03%) (41.59%) (21.08%) (20.53%)
Operating Cash Flow Margin
(11.79%) 0.08% 26.16% (62.99%) (57.35%) (27.22%) (39.49%) (15.34%) (3.71%) (4.43%)

Fold the line items

In millions of $ except per-share values · columns are period end dates